• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘中的隐匿性合并症:个性化治疗方法的视角

Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach.

作者信息

Maule Matteo, Olivieri Bianca, Guarnieri Gabriella, De Franceschi Lucia, Martinelli Nicola, Vaia Rachele, Argentino Giuseppe, Vianello Andrea, Senna Gianenrico, Caminati Marco

机构信息

Allergy Unit and Asthma Center, Verona University Hospital, 37134 Verona, Italy.

Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, 35128 Padua, Italy.

出版信息

J Clin Med. 2023 Mar 15;12(6):2294. doi: 10.3390/jcm12062294.

DOI:10.3390/jcm12062294
PMID:36983294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10059265/
Abstract

Bronchial asthma is the most frequent inflammatory non-communicable condition affecting the airways worldwide. It is commonly associated with concomitant conditions, which substantially contribute to its burden, whether they involve the lung or other districts. The present review aims at providing an overview of the recent acquisitions in terms of asthma concomitant systemic conditions, besides the commonly known respiratory comorbidities. The most recent research has highlighted a number of pathobiological interactions between asthma and other organs in the view of a shared immunological background underling different diseases. A bi-univocal relationship between asthma and common conditions, including cardiovascular, metabolic or neurodegenerative diseases, as well as rare disorders such as sickle cell disease, α1-Antitrypsin deficiency and immunologic conditions with hyper-eosinophilia, should be considered and explored, in terms of diagnostic work-up and long-term assessment of asthma patients. The relevance of that acquisition is of utmost importance in the management of asthma patients and paves the way to a new approach in the light of a personalized medicine perspective, besides targeted therapies.

摘要

支气管哮喘是全球范围内影响气道最常见的炎症性非传染性疾病。它通常与伴随疾病相关,这些伴随疾病无论涉及肺部还是其他部位,都极大地加重了其负担。本综述旨在概述哮喘伴随的全身性疾病的最新研究成果,以及常见的呼吸道合并症。最近的研究强调了在不同疾病共有的免疫背景下,哮喘与其他器官之间的一些病理生物学相互作用。在哮喘患者的诊断检查和长期评估方面,应考虑并探索哮喘与常见疾病(包括心血管疾病、代谢性疾病或神经退行性疾病)以及罕见疾病(如镰状细胞病、α1抗胰蛋白酶缺乏症和高嗜酸性粒细胞增多的免疫性疾病)之间的双向关系。这一研究成果在哮喘患者的管理中至关重要,除了靶向治疗外,还为基于个性化医疗视角的新方法铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff7/10059265/eab44e8fdda1/jcm-12-02294-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff7/10059265/eab44e8fdda1/jcm-12-02294-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff7/10059265/eab44e8fdda1/jcm-12-02294-g001.jpg

相似文献

1
Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach.哮喘中的隐匿性合并症:个性化治疗方法的视角
J Clin Med. 2023 Mar 15;12(6):2294. doi: 10.3390/jcm12062294.
2
Low-grade disease activity in early life precedes childhood asthma and allergy.早年的低度疾病活动先于儿童哮喘和过敏。
Dan Med J. 2016 Aug;63(8).
3
Diagnosis and Management of Allergic Rhinitis in Asthmatic Children.哮喘儿童过敏性鼻炎的诊断与管理
J Asthma Allergy. 2023 Jan 5;16:45-57. doi: 10.2147/JAA.S281439. eCollection 2023.
4
The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.以学校为基础的家庭哮喘教育项目对5至18岁确诊哮喘儿童生活质量和哮喘发作次数的有效性:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):69-81. doi: 10.11124/jbisrir-2015-2335.
5
Alpha1-antitrypsin deficiency and asthma.α1-抗胰蛋白酶缺乏与哮喘。
Monaldi Arch Chest Dis. 2022 Feb 22;92(4). doi: 10.4081/monaldi.2022.2179.
6
[Uncontrolled asthma: importance of phenotypes and local and systemic eosinophilia].[未控制的哮喘:表型以及局部和全身嗜酸性粒细胞增多的重要性]
Rev Med Liege. 2014;69 Spec No:62-5.
7
Asthma, inflammation, eosinophils and bronchial hyperresponsiveness.哮喘、炎症、嗜酸性粒细胞与支气管高反应性。
Clin Exp Allergy. 1992 Feb;22(2):187-97. doi: 10.1111/j.1365-2222.1992.tb03072.x.
8
Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.托拉塞米致嗜酸性肉芽肿伴多血管炎血管性紫癜。
Acta Dermatovenerol Croat. 2022 Sep;30(2):116-118.
9
Exacerbations of asthma without sputum eosinophilia.无痰嗜酸性粒细胞增多的哮喘加重
Thorax. 1995 Oct;50(10):1057-61. doi: 10.1136/thx.50.10.1057.
10
Does blood eosinophilia in wheezing infants predict later asthma? A prospective 18-20-year follow-up.喘息婴儿的血液嗜酸性粒细胞增多是否预示着日后会患哮喘?一项为期18至20年的前瞻性随访研究。
Allergy Asthma Proc. 2007 Mar-Apr;28(2):163-9. doi: 10.2500/app.2007.28.2946.

引用本文的文献

1
Pediatric asthma comorbidities: Global impact and unmet needs.儿童哮喘合并症:全球影响与未满足的需求
World Allergy Organ J. 2024 May 22;17(5):100909. doi: 10.1016/j.waojou.2024.100909. eCollection 2024 May.
2
Obese Asthma Phenotype Is Associated with hsa-miR-26a-1-3p and hsa-miR-376a-3p Modulating the IGF Axis.肥胖型哮喘表型与 hsa-miR-26a-1-3p 和 hsa-miR-376a-3p 调节 IGF 轴有关。
Int J Mol Sci. 2023 Jul 18;24(14):11620. doi: 10.3390/ijms241411620.

本文引用的文献

1
Rethinking blood eosinophil counts: Epidemiology, associated chronic diseases, and increased risks of cardiovascular disease.重新审视血液嗜酸性粒细胞计数:流行病学、相关慢性疾病及心血管疾病风险增加
J Allergy Clin Immunol Glob. 2022 Nov;1(4):233-240. doi: 10.1016/j.jacig.2022.09.001. Epub 2022 Sep 12.
2
Eosinophilic granulomatosis with polyangiitis: A review.嗜酸性肉芽肿伴多血管炎:综述。
Autoimmun Rev. 2023 Jan;22(1):103219. doi: 10.1016/j.autrev.2022.103219. Epub 2022 Oct 22.
3
Right ventricular-pulmonary arterial uncoupling in mild-to-moderate asthma.
轻至中度哮喘中的右心室-肺动脉解偶联
J Asthma. 2023 Mar;60(3):543-552. doi: 10.1080/02770903.2022.2073548. Epub 2022 May 12.
4
Association Between Asthma and All-Cause Mortality and Cardiovascular Disease Morbidity and Mortality: A Meta-Analysis of Cohort Studies.哮喘与全因死亡率以及心血管疾病发病率和死亡率之间的关联:队列研究的荟萃分析
Front Cardiovasc Med. 2022 Mar 17;9:861798. doi: 10.3389/fcvm.2022.861798. eCollection 2022.
5
Impact of Obesity on Response to Biologic Therapies in Patients with Inflammatory Bowel Diseases.肥胖对炎症性肠病患者生物治疗反应的影响。
BioDrugs. 2022 Mar;36(2):197-203. doi: 10.1007/s40259-022-00522-0. Epub 2022 Mar 23.
6
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study.重度哮喘的真实世界生物制剂使用及转换模式:来自国际重度哮喘注册研究和美国CHRONICLE研究的数据
J Asthma Allergy. 2022 Jan 13;15:63-78. doi: 10.2147/JAA.S328653. eCollection 2022.
7
Therapeutic effect of statins on airway remodeling during asthma.他汀类药物治疗哮喘气道重塑的疗效。
Expert Rev Respir Med. 2022 Jan;16(1):17-24. doi: 10.1080/17476348.2021.1987890. Epub 2021 Oct 28.
8
Neuroimaging and biomarker evidence of neurodegeneration in asthma.神经影像学和生物标志物在哮喘神经退行性变中的证据。
J Allergy Clin Immunol. 2022 Feb;149(2):589-598.e6. doi: 10.1016/j.jaci.2021.09.010. Epub 2021 Sep 15.
9
Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index.成人而非儿童期起病的哮喘与代谢综合征相关,且独立于体重指数。
Respir Med. 2021 Nov;188:106603. doi: 10.1016/j.rmed.2021.106603. Epub 2021 Sep 10.
10
Nonrespiratory Comorbidities in Asthma.哮喘的非呼吸性合并症。
J Allergy Clin Immunol Pract. 2021 Nov;9(11):3887-3897. doi: 10.1016/j.jaip.2021.08.027. Epub 2021 Sep 4.